drugset / Trial / NCT00125203
Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)
Phase 2/3
Completed
20 enrolled
The University of Texas Health Science Center at San Antonio
ALS Association · collabCarolinas MDA Neuromuscular/ALS Center-Carolinas Medical System · collabUniversity of Kansas · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of Myobloc in ALS patients who are having excessive drooling. The primary goal of the study is to determine if the patient perceives a benefit from the Myobloc in controlling excessive drooling.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum Toxin Type B | Unknown | — | Other |